![Frontiers | The future of evolutionary medicine: sparking innovation in biomedicine and public health Frontiers | The future of evolutionary medicine: sparking innovation in biomedicine and public health](https://www.frontiersin.org/files/MyHome%20Article%20Library/997136/997136_Thumb_400.jpg)
Frontiers | The future of evolutionary medicine: sparking innovation in biomedicine and public health
![Frontiers | From the Approach to the Concept: One Health in Latin America-Experiences and Perspectives in Brazil, Chile, and Colombia Frontiers | From the Approach to the Concept: One Health in Latin America-Experiences and Perspectives in Brazil, Chile, and Colombia](https://www.frontiersin.org/files/Articles/687110/fpubh-09-687110-HTML-r1/image_m/fpubh-09-687110-g001.jpg)
Frontiers | From the Approach to the Concept: One Health in Latin America-Experiences and Perspectives in Brazil, Chile, and Colombia
![SCA7 Mouse Cerebellar Pathology Reveals Preferential Downregulation of Key Purkinje Cell-Identity Genes and Shared Disease Signature with SCA1 and SCA2 | Journal of Neuroscience SCA7 Mouse Cerebellar Pathology Reveals Preferential Downregulation of Key Purkinje Cell-Identity Genes and Shared Disease Signature with SCA1 and SCA2 | Journal of Neuroscience](https://www.jneurosci.org/sites/default/files/highwire/jneuro/41/22.cover-source.jpg)
SCA7 Mouse Cerebellar Pathology Reveals Preferential Downregulation of Key Purkinje Cell-Identity Genes and Shared Disease Signature with SCA1 and SCA2 | Journal of Neuroscience
![Defibrotide plus best standard of care compared with best standard of care alone for the prevention of sinusoidal obstruction syndrome (HARMONY): a randomised, multicentre, phase 3 trial - The Lancet Haematology Defibrotide plus best standard of care compared with best standard of care alone for the prevention of sinusoidal obstruction syndrome (HARMONY): a randomised, multicentre, phase 3 trial - The Lancet Haematology](https://www.thelancet.com/cms/asset/ac0f6e8f-1595-43df-8688-3b57aa935a35/gr1.jpg)
Defibrotide plus best standard of care compared with best standard of care alone for the prevention of sinusoidal obstruction syndrome (HARMONY): a randomised, multicentre, phase 3 trial - The Lancet Haematology
![Contextual drive of neuronal responses in mouse V1 in the absence of feedforward input | Science Advances Contextual drive of neuronal responses in mouse V1 in the absence of feedforward input | Science Advances](https://www.science.org/cms/10.1126/sciadv.add2498/asset/f4966437-9e86-4155-b356-886ceba18ad0/assets/images/large/sciadv.add2498-f1.jpg)
Contextual drive of neuronal responses in mouse V1 in the absence of feedforward input | Science Advances
![Amazon.com: Zazzee Extra Strength Green Tea 20:1 Extract, 6000 mg Strength, 50% EGCG, 98% Polyphenols and 80% Catcehins, 150 Vegan Capsules, 5 Month Supply, Standardized and Concentrated 20X Potency, Non-GMO : Health & Household Amazon.com: Zazzee Extra Strength Green Tea 20:1 Extract, 6000 mg Strength, 50% EGCG, 98% Polyphenols and 80% Catcehins, 150 Vegan Capsules, 5 Month Supply, Standardized and Concentrated 20X Potency, Non-GMO : Health & Household](https://m.media-amazon.com/images/I/71Yg098AmRL._AC_UF350,350_QL80_.jpg)
Amazon.com: Zazzee Extra Strength Green Tea 20:1 Extract, 6000 mg Strength, 50% EGCG, 98% Polyphenols and 80% Catcehins, 150 Vegan Capsules, 5 Month Supply, Standardized and Concentrated 20X Potency, Non-GMO : Health & Household
![Magnitude of Blood Pressure Change After Endovascular Therapy and Outcomes: Insight From the BP-TARGET Trial | Stroke Magnitude of Blood Pressure Change After Endovascular Therapy and Outcomes: Insight From the BP-TARGET Trial | Stroke](https://www.ahajournals.org/cms/asset/da784ec4-eb10-4f44-a1c6-2e754cad1e04/strokeaha.121.036701.fig05.jpg)